Acoustic Delivery of Plasma Low-Density Lipoprotein into Liver via ApoB100-Targeted Microbubbles Inhibits Atherosclerotic Plaque Growth
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers developed targeted microbubbles to capture and degrade LDL cholesterol, offering a new strategy to reduce cardiovascular disease risk. This approach enhances LDL clearance in the liver, inhibiting atherosclerosis progression.
Area Of Science
- Biomedical Engineering
- Cardiovascular Research
- Nanotechnology
Background
- Atherosclerosis, driven by high low-density lipoprotein cholesterol (LDL-C), is a major cause of global mortality.
- Existing cholesterol-lowering drugs are insufficient for preventing recurrent cardiovascular events.
- Novel strategies are needed to effectively reduce plasma LDL-C levels.
Purpose Of The Study
- To develop a novel approach using antibody-coated microbubbles for targeted LDL-C reduction.
- To investigate the efficacy of microbubbles in capturing LDL particles and promoting their clearance.
- To evaluate the potential of ultrasound-mediated enhancement of LDL degradation in the liver.
Main Methods
- Development of gas-filled microbubbles coated with anti-Apolipoprotein B-100 (ApoB-100) antibodies (MB<sub>ApoB100</sub>).
- In vivo administration of targeted MB<sub>ApoB100</sub> to capture LDL particles, forming LDL-MB<sub>ApoB100</sub> complexes.
- Assessment of LDL-MB<sub>ApoB100</sub> complex uptake by Kupffer cells and liver cells using immunofluorescence and lipidomic analyses.
- Application of ultrasound irradiation to induce acoustic cavitation and enhance LDL degradation in the liver.
Main Results
- Targeted MB<sub>ApoB100</sub> selectively captured LDL particles in the bloodstream.
- LDL-MB<sub>ApoB100</sub> complexes were transported to the liver, potentially via Kupffer cells, and processed into bile acids.
- Ultrasound irradiation significantly enhanced LDL delivery into liver cells and accelerated degradation, inhibiting atherosclerotic plaque growth.
Conclusions
- Microbubble-based LDL capture offers a promising strategy for reducing plasma LDL-C levels.
- Ultrasound-enhanced degradation of LDL-MB<sub>ApoB100</sub> complexes in the liver accelerates cholesterol clearance.
- This approach demonstrates potential for inhibiting atherosclerosis progression and managing cardiovascular disease risk.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Overview
In response to tissue injury and infection, mast cells initiate inflammation. Mast cells release chemicals that increase the permeability of adjacent blood capillaries and attract additional immune cells to the wound or site of infection. Neutrophils are phagocytic leukocytes that exit the bloodstream and engulf invading microbes. Blood clotting platelets seal the wound and fibers create a scaffold for wound healing. Macrophages engulf aging neutrophils to end the acute inflammatory...